Source: BioPortfolio

Cesca: Cesca Therapeutics Inc KOOL Financial and Strategic SWOT Analysis Review Report Updated 28032019 Prices from USD $106

Cesca Therapeutics Inc KOOL Financial and Strategic SWOT Analysis Review provides you an indepth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view o...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Chris Xu's photo - Chairman & CEO of Cesca

Chairman & CEO

Chris Xu

CEO Approval Rating

77/100

Read more